NCT00534989已完成不适用
Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10
- 主要终点
- Prognosis
研究概览
简要总结
Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Non-Hodgkin's Lymphoma or Hodgkin's Disease
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with NHL and HD undergoing HDC and ASCT
排除标准
- 未提供
结局指标
主要结局
Prognosis
时间窗: overall
次要结局
未报告次要终点
研究者
Dr. Naeem A. Chaudhri
Principal Investigator
King Faisal Specialist Hospital & Research Center
相似试验
已完成
不适用
Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma or Hodgkin's DiseaseLymphoma, Non-HodgkinHodgkin DiseaseNCT00534820King Faisal Specialist Hospital & Research Center450
已完成
不适用
Role of FDG PET, Immune and Hypoxic Marker in NSCLCCarcinoma, Non-Small-Cell LungNCT02519062Istituto Clinico Humanitas130
已完成
不适用
FDG-PET-CT and Biomarkers in Esophageal CancerGastrointestinal DiseaseEsophageal CancerNCT00833625M.D. Anderson Cancer Center31
Unknown
不适用
Evaluation of the Diagnostic Value of PET (18F-FDG) in Chronic Graft Versus Host Disease (cGVH)Chronic Graft Versus Host DiseaseNCT02352064University Hospital, Caen26
终止
不适用
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing ChemotherapyLung CancerNCT00424138American College of Radiology Imaging Network96